Should ER-Low Breast Cancer Patients Be Offered Endocrine Therapy?

Breast Cancer Berita

Should ER-Low Breast Cancer Patients Be Offered Endocrine Therapy?
Malignant Breast NeoplasmBreast CarcinomaEndocrine Therapy
  • 📰 Medscape
  • ⏱ Reading Time:
  • 63 sec. here
  • 16 min. at publisher
  • 📊 Quality Score:
  • News: 74%
  • Publisher: 55%

Experts assessed whether patients with ER-low breast cancer should be offered endocrine therapy.

For women with early-stage estrogen-receptor positive breast cancer , adjuvant endocrine therapy is known to decrease the likelihood of recurrence and improve survival, while omitting the therapy is associated with a higher risk of death.

Endocrine therapy, the investigators say, should therefore be offered to all patients with ER-low cancers, at least until it can be determined which subgroups are most likely to benefit., of the Mayo Clinic in Rochester, Minnesota, and her colleagues looked at 2018-2020 data from the National Cancer Database for more than 350,000 female patients with stages 1-3, ER+ breast cancer.

Forty-two percent of patients did not undergo AET as part of their treatment regimen, with various tumor factors seen associated with AET omission. At a median 3 years of follow-up, 586 patients had died. After the researchers controlled for age, comorbidities, year of diagnosis, tumor factors, and pathologic stage, the effect of omitting AET still resulted in significantly worse survival .

"We are not yet at the point of saying to patients, 'you have residual disease after chemotherapy. Let's check your tumor to see if it is the basal or luminal subtype.' But that is something that we are planning to look into. What is most important right now is that clinicians be aware of these data, and that there is a suggestion that omitting endocrine therapy may have detrimental effects on survival in this subgroup of patients.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Medscape /  🏆 386. in US

Malignant Breast Neoplasm Breast Carcinoma Endocrine Therapy Estrogen Receptor Positive Breast Carcinoma Estrogen Receptor Positive Breast Cancer ER+ Breast Cancer Oestrogen Receptor-Positive Breast Cancer Oestrogen Receptor Positive Breast Carcinoma Oestrogen Receptor Positive Breast Cancer Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

‘Toxic workplace’: Questions swirl around organization after Miss USA, Miss Teen USA resign‘Toxic workplace’: Questions swirl around organization after Miss USA, Miss Teen USA resignThe race raised more than $19,000 for members of underserved communities living with breast cancer.
Baca lebih lajut »

See How These Breast Cancer Survivors Turned Their Mastectomy Scars Into Art with Stunning Tattoos (Exclusive)See How These Breast Cancer Survivors Turned Their Mastectomy Scars Into Art with Stunning Tattoos (Exclusive)Kerry Wright, 54, and two other breast cancer survivors took back their bodies and turned their mastectomy scars into art with stunning tattoos. The non-profit Personal Ink helped connect them with volunteer tattoo artists to make it happen.
Baca lebih lajut »

Olivia Munn Had a 'Full Hysterectomy' Amid Breast Cancer BattleOlivia Munn Had a 'Full Hysterectomy' Amid Breast Cancer BattleOlivia Munn underwent a hysterectomy in April amid her breast cancer battle, which she publicly revealed one month earlier
Baca lebih lajut »

Olivia Munn says she had a hysterectomy amid her cancer journey: ‘It was the best decision for me’Olivia Munn says she had a hysterectomy amid her cancer journey: ‘It was the best decision for me’Actress Olivia Munn continues to share her journey since being diagnosed with breast cancer last year.
Baca lebih lajut »

Chicago woman encourages women to prioritize own health after beating aggressive form of breast cancerChicago woman encourages women to prioritize own health after beating aggressive form of breast cancerClaudette Soto, 44, has a lot to celebrate this Mother’s Day, after beating an aggressive form of breast cancer.
Baca lebih lajut »

Barclays upgrades a little-known biotech stock that it says can more than doubleBarclays upgrades a little-known biotech stock that it says can more than doubleThis drug discovery stock can benefit from expansion of its breast cancer treatment.
Baca lebih lajut »



Render Time: 2025-02-25 02:13:54